Global Radiofrequency Devices Market
市场规模（十亿美元）
CAGR :
% 
USD
3.87 Billion
USD
10.80 Billion
2022
2030
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3.87 Billion |
 Market Size (Forecast Year) |
USD 10.80 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球射頻設備市場，按產品（一次性、資本、可重複使用設備）、類型（單極射頻消融、雙極射頻消融）、應用（心律不整、阻塞性睡眠呼吸中止症、癌症、疼痛管理、皮膚科、婦科）、最終用戶（醫院、癌症研究機構、門診手術中心）劃分——行業趨勢和預測到 2030 年。
射頻設備市場分析及規模
人們對微創手術的偏好日益增長，射頻消融系統在不損傷其他組織的情況下治療特定組織部位的能力不斷提升，城市化進程加快，以及人們對射頻消融設備認知度的不斷提升，這些都是推動射頻設備市場發展的主要因素。此外，在預測的2023-2030年期間，技術進步和現代化的持續推進將為射頻設備市場帶來新的機會。
Data Bridge Market Research 分析，射頻設備市場在 2022 年的規模為 38.7 億美元，預計到 2030 年將達到 108 億美元，在 2023 年至 2030 年的預測期內複合年增長率為 13.7%。除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、管道分析、定價分析和監管框架。
射頻設備市場範圍和細分
|
報告指標 |
細節 |
|
預測期 |
2023年至2030年 |
|
基準年 |
2022 |
|
歷史歲月 |
2021（可自訂為 2015 - 2020 年） |
|
定量單位 |
收入（十億美元）、銷售（單位）、定價（美元） |
|
涵蓋的領域 |
產品（一次性、固定、可重複使用設備）、類型（單極射頻消融、雙極射頻消融）、應用（心律不整、阻塞性睡眠呼吸中止症、癌症、疼痛管理、皮膚科、婦科）、最終用戶（醫院、癌症研究機構、門診手術中心） |
|
覆蓋國家 |
北美洲的美國、加拿大和墨西哥、德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其、歐洲其他地區、中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓、亞太地區 (APAC) 的其他地區、沙烏地阿拉伯、阿聯酋、南非、埃及、以色列、中東和非洲 (MEA) 的其他地區、其他地區的歐洲地區 |
|
涵蓋的市場參與者 |
波士頓科學公司（美國）、美敦力公司（愛爾蘭）、AngioDynamics公司（美國）、史賽克公司（美國）、ATRICURE公司（美國）、奧林巴斯株式會社（日本）、Novomed公司（印度）、AVNS公司（比利時）、西門子醫療私人有限公司（德國）、Venclose（美國）、阿伯利斯科公司（美國）、美國） NV（中國）、AES公司（美國）、Integer Holdings公司（美國）、MedWaves公司（美國）、Teleflex Incorporated公司（美國）、Baylis Medical公司（美國） |
|
市場機會 |
|
市場定義
射頻 (RF) 設備用於收緊皮膚、刺激膠原蛋白生成、透過加熱和破壞脂肪細胞來塑造體形以及煥發臉部年輕光彩。老年人口的成長和對外表的重視是推動射頻設備市場成長的兩大因素。隨著年齡的增長，皮膚外層會變薄，因為含色素的細胞（黑色素細胞）會減少。老年人的皮膚看起來更蒼白、更薄、更透明。射頻設備用於刺激膠原蛋白生成、收緊肌膚和煥發臉部年輕光彩。
射頻設備市場動態
驅動程式
- 對微創手術的需求增加
人們對微創手術和治療的日益青睞、射頻設備的技術進步，以及其他相對於其他美容手術的健康和經濟優勢。近年來，外科領域最重要的科學進步之一是微創手術 (MIS) 的發展。人們不斷努力以最少的併發症、恢復時間和住院次數來實現所需的手術效果，這是需求成長的原因。這些因素推動了市場的成長。
- 家庭醫療保健的使用率不斷提高
利用家庭醫療保健趨勢推廣家用設備，並綜效拓展新興市場，是加速該產業成長的兩種可能。由於新冠疫情，居家醫療保健已成為一種流行的治療選擇。因此，家庭醫療保健在各個醫療領域正變得越來越受歡迎。居家射頻美容的概念並不新鮮，早在疫情爆發前就已經在市場上出現。此外，對於非專業人士來說，各種低成本的家用射頻美容工具和設備也已開發出來。射頻美容設備的生產商可以與當地企業和醫療保健提供者合作，在當地市場推廣其產品，從而獲得豐厚的業務成果並建立龐大的客戶群。
機會
- 技術進步
射頻微針療法是一種非手術美容療法，有助於恢復肌膚年輕光彩，並可藉助射頻驅動的美容設備進行。此療法有助於恢復皮膚天然的膠原蛋白生成能力，而膠原蛋白正是肌膚保持年輕光彩的關鍵。此外，射頻美容設備的最新進展融合了多種不同技術，並進行了多種組合。隨著這些技術的進步，熱門市場參與者面臨越來越大的壓力，需要開發用於射頻消融和美容手術的新產品。
限制/挑戰
- 射頻美容療程費用高昂
美容治療報銷政策的缺失、經驗豐富的美容治療人員的缺乏以及射頻美容治療的高昂費用，都是阻礙該行業發展的障礙。保險公司必須付出巨大努力來改變現有的報銷規則。就美容治療而言，此類政策的缺失可能會阻礙其發展。此外，由於治療過程中可能會出現暫時性燒傷和腫脹，因此必須由訓練有素的專業人員進行。缺乏合格的員工也可能導致最終用戶對這項技術的接受率較低。
此外，腫瘤復發風險的增加和治療成本的上升將阻礙市場成長，而與組織治療部位灼熱感相關的複雜性的增加將在預測期內進一步挑戰射頻設備市場的成長。
本射頻設備市場報告詳細介紹了最新發展動態、貿易法規、進出口分析、生產分析、價值鏈優化、市場份額、國內和本地市場參與者的影響，並分析了新興收入來源、市場法規變化、戰略市場增長分析、市場規模、品類市場增長、應用領域和市場主導地位、產品審批、產品發布、地域擴張以及市場技術創新等方面的機遇。如需了解更多關於射頻設備市場的信息，請聯繫 Data Bridge 市場研究部門獲取分析師簡報，我們的團隊將協助您做出明智的市場決策，實現市場成長。
COVID-19對射頻設備市場的影響
最新動態
- 2022 年，史賽克推出了適用於高要求足部和踝部應用的 EasyFuseTM 動態壓縮系統。
- 2022 年，波士頓科學公司將獲得 FDA 批准用於深部腦部刺激治療的下一代影像導引程式軟體。
- 2022 年 - 下一個前沿：新型 BD 細胞分選器將為科學家提供前所未有的健康和疾病洞察。
全球射頻設備市場範圍
射頻設備市場根據產品、類型、應用和最終用戶進行細分。這些細分市場的成長將幫助您分析行業中成長緩慢的細分市場，並為用戶提供有價值的市場概覽和市場洞察，幫助他們做出策略決策，確定核心市場應用。
產品
- 一次性的
- 首都
- 可重複使用設備
類型
- 單極射頻消融
- 雙極射頻消融
應用
- 心律不整
- 阻塞性睡眠呼吸中止症
- 癌症
- 疼痛管理
- 皮膚科
- 婦科
最終用戶
- 醫院
- 癌症研究機構
- 門診手術中心
射頻設備市場區域分析/洞察
對射頻設備市場進行了分析，並按國家、產品、類型、應用和最終用戶提供了市場規模洞察和趨勢，如上所述。
射頻設備市場報告涉及的國家有：北美的美國、加拿大和墨西哥，歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其，歐洲的其他地區，中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓，亞太地區的其他地區，沙烏地阿拉伯、阿聯酋、南非、埃及、以色列，中東和非洲的其他地區，沙烏地阿拉伯、阿聯酋、南非、埃及、以色列，中東和其他地區的其他地區，沙烏地阿拉伯、阿聯酋、南非、埃及、以色列，中東和其他地區的其他地區，沙烏地阿拉伯、阿聯酋、南非、埃及、以色列，中東和其他地區的其他地區，沙烏地阿拉伯。
由於癌症發病率上升、醫療保健改善和技術先進，北美在射頻設備市場佔據主導地位，該地區具有巨大的潛力和精確度。
由於膀胱癌、食道癌、肝癌、胰腺癌等癌症的發病率不斷上升，加上美國主要製造商的廣泛存在，以及技術進步和外國投資的不斷增加，預計亞太地區在 2023 年至 2030 年的預測期內將以最高的增長率增長。
報告的國家部分還提供了各個市場的影響因素以及國內市場監管變化，這些變化會影響市場的當前和未來趨勢。下游和上游價值鏈分析、技術趨勢、波特五力模型分析以及案例研究等數據點是預測各國市場狀況的一些指標。此外，在對國家/地區數據進行預測分析時，還考慮了全球品牌的存在和可用性，以及它們因本土和國內品牌的激烈競爭或稀缺而面臨的挑戰，國內關稅和貿易路線的影響。
醫療保健基礎設施成長安裝基礎和新技術滲透
射頻設備市場也為您提供詳細的市場分析，涵蓋各國醫療設備資本支出的成長情況、射頻設備市場中各類產品的安裝基數、生命線曲線技術的影響以及醫療監管環境的變化及其對射頻設備市場的影響。數據涵蓋2011年至2021年的歷史時期。
競爭格局與射頻設備市場佔有率分析
射頻設備市場競爭格局提供了按競爭對手劃分的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、全球佈局、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據僅與公司在射頻設備市場的重點相關。
射頻設備市場的一些主要參與者包括：
- 波士頓科學公司（美國）
- 美敦力（愛爾蘭）
- AngioDynamics（美國）
- 史賽克（美國）
- ATRICURE, INC.（美）
- 奧林巴斯株式會社（日本）
- Novomed（印度）
- AVNS（比利時）
- 西門子醫療私人有限公司（德國）
- Venclose, Inc.（美國）
- Cosman Medical, Inc.（美國）
- 雅培（美國）
- Terumo Europe NV（中國）
- AES（美國）
- Integer Holdings Corporation（美國）
- MedWaves, Inc.（美國）
- Teleflex Incorporated（美國）
- Baylis Medical Company, Inc（美國）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL RADIOFREQUENCY DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL RADIOFREQUENCY DEVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL RADIOFREQUENCY DEVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY TYPE
16.1 OVERVIEW
16.2 UNIPOLAR RADIOFREQUENCY ABLATION
16.3 BIPOLAR RADIOFREQUENCY ABLATION
17 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PRODUCT
17.1 OVERVIEW
17.2 CAPITAL EQUIPMENT
17.2.1 BY TYPE
17.2.1.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
17.2.1.2. FLUID-COOLED RADIOFREQUENCY ABLATORS
17.2.1.3. ROBOTIC CATHETER MANIPULATION SYSTEMS
17.2.1.4. OTHERS
17.2.2 BY MODALITY
17.2.2.1. STANDALONE
17.2.2.2. PORTABLE
17.2.2.3. BENCHTOP
17.2.2.4. HANDHELD
17.2.3 BY PROCEDURE TYPE
17.2.3.1. NON-INVASIVE RF DEVICE
17.2.3.2. MINIMALLY INVASIVE RF DEVICES
17.2.3.3. INVASIVE RF DEVICES
17.2.4 BY FREQUENCY
17.2.4.1. LOW-FREQUENCY RF DEVICES
17.2.4.2. HIGH-FREQUENCY RF DEVICES
17.2.5 OTHERS
17.3 REUSABLE EQUIPMENT
17.3.1 RF ELECTRODE
17.3.1.1. RF ABLATION SINGLE ELECTRODE KITS
17.3.1.2. RF ABLATION CLUSTER ELECTRODE KITS
17.3.1.3. RF ABLATION SWITCHING ELECTRODE KITS
17.3.1.4. RF ABLATION MULTIPLE ELECTRODE KITS
17.3.2 RF ABLATION PROBES
17.3.2.1. STERILE
17.3.2.2. NON-STERILE
17.3.3 RF ABLATION SYSTEM GROUNDING PAD
17.3.4 RF ABLATION SYSTEM EXTENSION CABLE
17.3.5 PATIENT-SPECIFIC ATTACHMENTS
17.3.6 CONDUCTIVE TIPS
17.3.7 HANDPIECES
17.3.8 OTHERS
17.4 DISPOSABLES
17.4.1 RF CANNULA
17.4.2 RF NEEDLES
17.4.3 RF CATHETERS
17.4.4 OTHERS
18 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PORTABILITY
18.1 OVERVIEW
18.2 STANDALONE
18.3 PORTABLE
18.4 BENCHTOP
18.5 HANDHELD
19 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY APPLICATION
19.1 OVERVIEW
19.2 CARDIOLOGY
19.2.1 ATRIAL FIBRILLATION
19.2.2 ATRIAL FLUTTER
19.2.3 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
19.2.4 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
19.2.5 OTHERS
19.3 ONCOLOGY
19.3.1 LIVER CANCER
19.3.2 KIDNEY CANCER
19.3.3 PROSTATE CANCER
19.3.4 LUNG CANCER
19.3.5 BONE METASTASIS
19.3.6 BREAST CANCER
19.3.7 OTHERS
19.4 ARRHYTHMIA
19.5 OBSTRUCTIVE SLEEP APNEA
19.6 PAIN MANAGEMENT
19.7 DERMATOLOGY
19.8 AESTHETIC AND COSMETIC
19.8.1 ACNE SCARS
19.8.2 STRETCH MARKS
19.8.3 SKIN TONNING
19.8.4 REFINES SKIN TEXTURE
19.8.5 PORES TIGHTENING
19.8.6 REDUCES AND SMOOTHS POST-OPERATIVE SCARS
19.8.7 REDUCES & SMOOTHES FINE LINES AND WRINKLES
19.8.8 FADES HYPERPIGMENTATION (PREGNANCY MASK & SUNSPOTS)
19.8.9 OTHERS
19.9 GYNECOLOGY
19.1 OTHERS
20 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 BY TYPE
20.2.1.1. PRIVATE
20.2.1.2. PUBLIC
20.2.2 BY LEVEL
20.2.2.1. TIER 1
20.2.2.2. TIER 2
20.2.2.3. TIER 3
20.3 MEDICAL SPAS
20.4 SPECIALTY CLINICS
20.5 CLINICAL LABORATORIES
20.6 CANCER RESEARCH INSTITUTES
20.7 CATHERIZATION LABORATORIES
20.8 AMBULATORY SURGICAL CENTERS
20.9 AESTHETIC AND COSMETIC CLINICS
20.1 OTHERS
21 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL SALES
21.3.1 ONLINE SALES
21.3.2 OFFLINE SALES
21.4 OTHERS
22 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: GLOBAL
22.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
22.3 COMPANY SHARE ANALYSIS: EUROPE
22.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
22.5 MERGERS & ACQUISITIONS
22.6 NEW PRODUCT DEVELOPMENT & APPROVALS
22.7 EXPANSIONS
22.8 REGULATORY CHANGES
22.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY GEOGRAPHY
GLOBAL RADIOFREQUENCY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 NORTH AMERICA
23.1.1 U.S.
23.1.2 CANADA
23.1.3 MEXICO
23.2 EUROPE
23.2.1 GERMANY
23.2.2 FRANCE
23.2.3 U.K.
23.2.4 ITALY
23.2.5 SPAIN
23.2.6 RUSSIA
23.2.7 TURKEY
23.2.8 BELGIUM
23.2.9 NETHERLANDS
23.2.10 SWITZERLAND
23.2.11 DENMARK
23.2.12 NORWAY
23.2.13 SWEDEN
23.2.14 FINLAND
23.2.15 POLAND
23.2.16 REST OF EUROPE
23.3 ASIA-PACIFIC
23.3.1 JAPAN
23.3.2 CHINA
23.3.3 SOUTH KOREA
23.3.4 INDIA
23.3.5 AUSTRALIA
23.3.6 SINGAPORE
23.3.7 THAILAND
23.3.8 MALAYSIA
23.3.9 INDONESIA
23.3.10 PHILIPPINES
23.3.11 VIETNAM
23.3.12 NEW ZEALAND
23.3.13 TAIWAN
23.3.14 REST OF ASIA-PACIFIC
23.4 SOUTH AMERICA
23.4.1 BRAZIL
23.4.2 ARGENTINA
23.4.3 REST OF SOUTH AMERICA
23.5 MIDDLE EAST AND AFRICA
23.5.1 SOUTH AFRICA
23.5.2 SAUDI ARABIA
23.5.3 UAE
23.5.4 EGYPT
23.5.5 ISRAEL
23.5.6 OMAN
23.5.7 QATAR
23.5.8 BAHRAIN
23.5.9 REST OF MIDDLE EAST AND AFRICA
23.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 GLOBAL RADIOFREQUENCY DEVICES MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY PROFILE
25.1 ANGIODYNAMICS, INC.
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 ARTHREX, INC
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 BOSTON SCIENTIFIC CORPORATION
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 ETHICON INC
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 KONINKLIJKE PHILIPS N.V.
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 BLOOMEA
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 MEDTRONIC
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 SUTTER MEDIZINTECHNIK GMBH
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 BVM MEDICAL
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 STRYKER
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 ADVANCED MICROSYSTEMS TECHNOLOGIES - A DIVISION OF SANMINA CORPORATION
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 ATRICURE, INC.
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 OLYMPUS
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 BAYLIS MEDICAL COMPANY INC.
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 NOVOMED
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 SIEMENS HEALTHCARE PRIVATE LIMITED
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
25.17 BD
25.17.1 COMPANY OVERVIEW
25.17.2 REVENUE ANALYSIS
25.17.3 GEOGRAPHIC PRESENCE
25.17.4 PRODUCT PORTFOLIO
25.17.5 RECENT DEVELOPMENTS
25.18 INTEGER HOLDINGS CORPORATION
25.18.1 COMPANY OVERVIEW
25.18.2 REVENUE ANALYSIS
25.18.3 GEOGRAPHIC PRESENCE
25.18.4 PRODUCT PORTFOLIO
25.18.5 RECENT DEVELOPMENTS
25.19 TELEFLEX INCORPORATED.
25.19.1 COMPANY OVERVIEW
25.19.2 REVENUE ANALYSIS
25.19.3 GEOGRAPHIC PRESENCE
25.19.4 PRODUCT PORTFOLIO
25.19.5 RECENT DEVELOPMENTS
25.2 TERUMO EUROPE NV
25.20.1 COMPANY OVERVIEW
25.20.2 REVENUE ANALYSIS
25.20.3 GEOGRAPHIC PRESENCE
25.20.4 PRODUCT PORTFOLIO
25.20.5 RECENT DEVELOPMENTS
25.21 ABBOTT
25.21.1 COMPANY OVERVIEW
25.21.2 REVENUE ANALYSIS
25.21.3 GEOGRAPHIC PRESENCE
25.21.4 PRODUCT PORTFOLIO
25.21.5 RECENT DEVELOPMENTS
25.22 AVNS
25.22.1 COMPANY OVERVIEW
25.22.2 REVENUE ANALYSIS
25.22.3 GEOGRAPHIC PRESENCE
25.22.4 PRODUCT PORTFOLIO
25.22.5 RECENT DEVELOPMENTS
25.23 F CARE SYSTEMS
25.23.1 COMPANY OVERVIEW
25.23.2 REVENUE ANALYSIS
25.23.3 GEOGRAPHIC PRESENCE
25.23.4 PRODUCT PORTFOLIO
25.23.5 RECENT DEVELOPMENTS
25.24 XCELLANCE MEDICAL TECHNOLOGIES PVT LTD
25.24.1 COMPANY OVERVIEW
25.24.2 REVENUE ANALYSIS
25.24.3 GEOGRAPHIC PRESENCE
25.24.4 PRODUCT PORTFOLIO
25.24.5 RECENT DEVELOPMENTS
25.25 BIOTRONIK SE & CO. KG
25.25.1 COMPANY OVERVIEW
25.25.2 REVENUE ANALYSIS
25.25.3 GEOGRAPHIC PRESENCE
25.25.4 PRODUCT PORTFOLIO
25.25.5 RECENT DEVELOPMENTS
25.26 STARMED CO., LTD.
25.26.1 COMPANY OVERVIEW
25.26.2 REVENUE ANALYSIS
25.26.3 GEOGRAPHIC PRESENCE
25.26.4 PRODUCT PORTFOLIO
25.26.5 RECENT DEVELOPMENTS
25.27 HOLOGIC, INC.
25.27.1 COMPANY OVERVIEW
25.27.2 REVENUE ANALYSIS
25.27.3 GEOGRAPHIC PRESENCE
25.27.4 PRODUCT PORTFOLIO
25.27.5 RECENT DEVELOPMENTS
25.28 OSYPKA AG
25.28.1 COMPANY OVERVIEW
25.28.2 REVENUE ANALYSIS
25.28.3 GEOGRAPHIC PRESENCE
25.28.4 PRODUCT PORTFOLIO
25.28.5 RECENT DEVELOPMENTS
25.29 MERIT MEDICAL SYSTEMS
25.29.1 COMPANY OVERVIEW
25.29.2 REVENUE ANALYSIS
25.29.3 GEOGRAPHIC PRESENCE
25.29.4 PRODUCT PORTFOLIO
25.29.5 RECENT DEVELOPMENTS
25.3 CONMED CORPORATION
25.30.1 COMPANY OVERVIEW
25.30.2 REVENUE ANALYSIS
25.30.3 GEOGRAPHIC PRESENCE
25.30.4 PRODUCT PORTFOLIO
25.30.5 RECENT DEVELOPMENTS
25.31 LUTRONIC CORPORATION
25.31.1 COMPANY OVERVIEW
25.31.2 REVENUE ANALYSIS
25.31.3 GEOGRAPHIC PRESENCE
25.31.4 PRODUCT PORTFOLIO
25.31.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL RADIOFREQUENCY DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL RADIOFREQUENCY DEVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL RADIOFREQUENCY DEVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY TYPE
16.1 OVERVIEW
16.2 UNIPOLAR RADIOFREQUENCY ABLATION
16.3 BIPOLAR RADIOFREQUENCY ABLATION
17 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PRODUCT
17.1 OVERVIEW
17.2 CAPITAL EQUIPMENT
17.2.1 BY TYPE
17.2.1.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
17.2.1.2. FLUID-COOLED RADIOFREQUENCY ABLATORS
17.2.1.3. ROBOTIC CATHETER MANIPULATION SYSTEMS
17.2.1.4. OTHERS
17.2.2 BY MODALITY
17.2.2.1. STANDALONE
17.2.2.2. PORTABLE
17.2.2.3. BENCHTOP
17.2.2.4. HANDHELD
17.2.3 BY PROCEDURE TYPE
17.2.3.1. NON-INVASIVE RF DEVICE
17.2.3.2. MINIMALLY INVASIVE RF DEVICES
17.2.3.3. INVASIVE RF DEVICES
17.2.4 BY FREQUENCY
17.2.4.1. LOW-FREQUENCY RF DEVICES
17.2.4.2. HIGH-FREQUENCY RF DEVICES
17.2.5 OTHERS
17.3 REUSABLE EQUIPMENT
17.3.1 RF ELECTRODE
17.3.1.1. RF ABLATION SINGLE ELECTRODE KITS
17.3.1.2. RF ABLATION CLUSTER ELECTRODE KITS
17.3.1.3. RF ABLATION SWITCHING ELECTRODE KITS
17.3.1.4. RF ABLATION MULTIPLE ELECTRODE KITS
17.3.2 RF ABLATION PROBES
17.3.2.1. STERILE
17.3.2.2. NON-STERILE
17.3.3 RF ABLATION SYSTEM GROUNDING PAD
17.3.4 RF ABLATION SYSTEM EXTENSION CABLE
17.3.5 PATIENT-SPECIFIC ATTACHMENTS
17.3.6 CONDUCTIVE TIPS
17.3.7 HANDPIECES
17.3.8 OTHERS
17.4 DISPOSABLES
17.4.1 RF CANNULA
17.4.2 RF NEEDLES
17.4.3 RF CATHETERS
17.4.4 OTHERS
18 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PORTABILITY
18.1 OVERVIEW
18.2 STANDALONE
18.3 PORTABLE
18.4 BENCHTOP
18.5 HANDHELD
19 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY APPLICATION
19.1 OVERVIEW
19.2 CARDIOLOGY
19.2.1 ATRIAL FIBRILLATION
19.2.2 ATRIAL FLUTTER
19.2.3 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
19.2.4 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
19.2.5 OTHERS
19.3 ONCOLOGY
19.3.1 LIVER CANCER
19.3.2 KIDNEY CANCER
19.3.3 PROSTATE CANCER
19.3.4 LUNG CANCER
19.3.5 BONE METASTASIS
19.3.6 BREAST CANCER
19.3.7 OTHERS
19.4 ARRHYTHMIA
19.5 OBSTRUCTIVE SLEEP APNEA
19.6 PAIN MANAGEMENT
19.7 DERMATOLOGY
19.8 AESTHETIC AND COSMETIC
19.8.1 ACNE SCARS
19.8.2 STRETCH MARKS
19.8.3 SKIN TONNING
19.8.4 REFINES SKIN TEXTURE
19.8.5 PORES TIGHTENING
19.8.6 REDUCES AND SMOOTHS POST-OPERATIVE SCARS
19.8.7 REDUCES & SMOOTHES FINE LINES AND WRINKLES
19.8.8 FADES HYPERPIGMENTATION (PREGNANCY MASK & SUNSPOTS)
19.8.9 OTHERS
19.9 GYNECOLOGY
19.1 OTHERS
20 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 BY TYPE
20.2.1.1. PRIVATE
20.2.1.2. PUBLIC
20.2.2 BY LEVEL
20.2.2.1. TIER 1
20.2.2.2. TIER 2
20.2.2.3. TIER 3
20.3 MEDICAL SPAS
20.4 SPECIALTY CLINICS
20.5 CLINICAL LABORATORIES
20.6 CANCER RESEARCH INSTITUTES
20.7 CATHERIZATION LABORATORIES
20.8 AMBULATORY SURGICAL CENTERS
20.9 AESTHETIC AND COSMETIC CLINICS
20.1 OTHERS
21 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL SALES
21.3.1 ONLINE SALES
21.3.2 OFFLINE SALES
21.4 OTHERS
22 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: GLOBAL
22.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
22.3 COMPANY SHARE ANALYSIS: EUROPE
22.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
22.5 MERGERS & ACQUISITIONS
22.6 NEW PRODUCT DEVELOPMENT & APPROVALS
22.7 EXPANSIONS
22.8 REGULATORY CHANGES
22.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY GEOGRAPHY
GLOBAL RADIOFREQUENCY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 NORTH AMERICA
23.1.1 U.S.
23.1.2 CANADA
23.1.3 MEXICO
23.2 EUROPE
23.2.1 GERMANY
23.2.2 FRANCE
23.2.3 U.K.
23.2.4 ITALY
23.2.5 SPAIN
23.2.6 RUSSIA
23.2.7 TURKEY
23.2.8 BELGIUM
23.2.9 NETHERLANDS
23.2.10 SWITZERLAND
23.2.11 DENMARK
23.2.12 NORWAY
23.2.13 SWEDEN
23.2.14 FINLAND
23.2.15 POLAND
23.2.16 REST OF EUROPE
23.3 ASIA-PACIFIC
23.3.1 JAPAN
23.3.2 CHINA
23.3.3 SOUTH KOREA
23.3.4 INDIA
23.3.5 AUSTRALIA
23.3.6 SINGAPORE
23.3.7 THAILAND
23.3.8 MALAYSIA
23.3.9 INDONESIA
23.3.10 PHILIPPINES
23.3.11 VIETNAM
23.3.12 NEW ZEALAND
23.3.13 TAIWAN
23.3.14 REST OF ASIA-PACIFIC
23.4 SOUTH AMERICA
23.4.1 BRAZIL
23.4.2 ARGENTINA
23.4.3 REST OF SOUTH AMERICA
23.5 MIDDLE EAST AND AFRICA
23.5.1 SOUTH AFRICA
23.5.2 SAUDI ARABIA
23.5.3 UAE
23.5.4 EGYPT
23.5.5 ISRAEL
23.5.6 OMAN
23.5.7 QATAR
23.5.8 BAHRAIN
23.5.9 REST OF MIDDLE EAST AND AFRICA
23.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 GLOBAL RADIOFREQUENCY DEVICES MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY PROFILE
25.1 ANGIODYNAMICS, INC.
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 ARTHREX, INC
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 BOSTON SCIENTIFIC CORPORATION
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 ETHICON INC
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 KONINKLIJKE PHILIPS N.V.
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 BLOOMEA
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 MEDTRONIC
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 SUTTER MEDIZINTECHNIK GMBH
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 BVM MEDICAL
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 STRYKER
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 ADVANCED MICROSYSTEMS TECHNOLOGIES - A DIVISION OF SANMINA CORPORATION
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 ATRICURE, INC.
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 OLYMPUS
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 BAYLIS MEDICAL COMPANY INC.
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 NOVOMED
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 SIEMENS HEALTHCARE PRIVATE LIMITED
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
25.17 BD
25.17.1 COMPANY OVERVIEW
25.17.2 REVENUE ANALYSIS
25.17.3 GEOGRAPHIC PRESENCE
25.17.4 PRODUCT PORTFOLIO
25.17.5 RECENT DEVELOPMENTS
25.18 INTEGER HOLDINGS CORPORATION
25.18.1 COMPANY OVERVIEW
25.18.2 REVENUE ANALYSIS
25.18.3 GEOGRAPHIC PRESENCE
25.18.4 PRODUCT PORTFOLIO
25.18.5 RECENT DEVELOPMENTS
25.19 TELEFLEX INCORPORATED.
25.19.1 COMPANY OVERVIEW
25.19.2 REVENUE ANALYSIS
25.19.3 GEOGRAPHIC PRESENCE
25.19.4 PRODUCT PORTFOLIO
25.19.5 RECENT DEVELOPMENTS
25.2 TERUMO EUROPE NV
25.20.1 COMPANY OVERVIEW
25.20.2 REVENUE ANALYSIS
25.20.3 GEOGRAPHIC PRESENCE
25.20.4 PRODUCT PORTFOLIO
25.20.5 RECENT DEVELOPMENTS
25.21 ABBOTT
25.21.1 COMPANY OVERVIEW
25.21.2 REVENUE ANALYSIS
25.21.3 GEOGRAPHIC PRESENCE
25.21.4 PRODUCT PORTFOLIO
25.21.5 RECENT DEVELOPMENTS
25.22 AVNS
25.22.1 COMPANY OVERVIEW
25.22.2 REVENUE ANALYSIS
25.22.3 GEOGRAPHIC PRESENCE
25.22.4 PRODUCT PORTFOLIO
25.22.5 RECENT DEVELOPMENTS
25.23 F CARE SYSTEMS
25.23.1 COMPANY OVERVIEW
25.23.2 REVENUE ANALYSIS
25.23.3 GEOGRAPHIC PRESENCE
25.23.4 PRODUCT PORTFOLIO
25.23.5 RECENT DEVELOPMENTS
25.24 XCELLANCE MEDICAL TECHNOLOGIES PVT LTD
25.24.1 COMPANY OVERVIEW
25.24.2 REVENUE ANALYSIS
25.24.3 GEOGRAPHIC PRESENCE
25.24.4 PRODUCT PORTFOLIO
25.24.5 RECENT DEVELOPMENTS
25.25 BIOTRONIK SE & CO. KG
25.25.1 COMPANY OVERVIEW
25.25.2 REVENUE ANALYSIS
25.25.3 GEOGRAPHIC PRESENCE
25.25.4 PRODUCT PORTFOLIO
25.25.5 RECENT DEVELOPMENTS
25.26 STARMED CO., LTD.
25.26.1 COMPANY OVERVIEW
25.26.2 REVENUE ANALYSIS
25.26.3 GEOGRAPHIC PRESENCE
25.26.4 PRODUCT PORTFOLIO
25.26.5 RECENT DEVELOPMENTS
25.27 HOLOGIC, INC.
25.27.1 COMPANY OVERVIEW
25.27.2 REVENUE ANALYSIS
25.27.3 GEOGRAPHIC PRESENCE
25.27.4 PRODUCT PORTFOLIO
25.27.5 RECENT DEVELOPMENTS
25.28 OSYPKA AG
25.28.1 COMPANY OVERVIEW
25.28.2 REVENUE ANALYSIS
25.28.3 GEOGRAPHIC PRESENCE
25.28.4 PRODUCT PORTFOLIO
25.28.5 RECENT DEVELOPMENTS
25.29 MERIT MEDICAL SYSTEMS
25.29.1 COMPANY OVERVIEW
25.29.2 REVENUE ANALYSIS
25.29.3 GEOGRAPHIC PRESENCE
25.29.4 PRODUCT PORTFOLIO
25.29.5 RECENT DEVELOPMENTS
25.3 CONMED CORPORATION
25.30.1 COMPANY OVERVIEW
25.30.2 REVENUE ANALYSIS
25.30.3 GEOGRAPHIC PRESENCE
25.30.4 PRODUCT PORTFOLIO
25.30.5 RECENT DEVELOPMENTS
25.31 LUTRONIC CORPORATION
25.31.1 COMPANY OVERVIEW
25.31.2 REVENUE ANALYSIS
25.31.3 GEOGRAPHIC PRESENCE
25.31.4 PRODUCT PORTFOLIO
25.31.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
